NM_001114753.3:c.-9G>A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 1P and 1B. BP5PS3_Supporting

This summary comes from the ClinGen Evidence Repository: The NM_001114753.3: c.-9G>A variant is located in the 5' UTR of ENG. Because the variant is located in the 5' UTR, is it not expected to alter the amino acid sequence. The highest population minor allele frequency in gnomAD v2.1.1 is 0.0007942 (76/95698 alleles) in the European (non-Finnish) population. This variant has been observed in patients with an alternate molecular basis for disease (patients also carry a likely pathogenic/pathogenic ACVRL1 variant) (BP5; Internal lab contributors). Expression studies showed this variant causes a small reduction (~18.4%) of endoglin compared to wild type (PS3_Supporting, PMID:22192717). Due to conflicting evidence, this variant is classified as a variant of uncertain significance for autosomal dominant hereditary hemorrhagic telangiectasia based on the ACMG/AMP criteria applied, as specified by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel: PS3_Supporting, BP5 (specification version 1.0.0; 1/4/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA5253269/MONDO:0008535/136

Frequency

Genomes: 𝑓 0.00041 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00082 ( 1 hom. )

Consequence

ENG
NM_001114753.3 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Uncertain significance reviewed by expert panel P:1U:11B:3

Conservation

PhyloP100: 0.0650

Publications

6 publications found
Variant links:
Genes affected
ENG (HGNC:3349): (endoglin) This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds to the beta1 and beta3 peptides with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant multisystemic vascular dysplasia. This gene may also be involved in preeclampsia and several types of cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]
ENG Gene-Disease associations (from GenCC):
  • telangiectasia, hereditary hemorrhagic, type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • hereditary hemorrhagic telangiectasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • juvenile polyposis syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PS3
For more information check the summary or visit ClinGen Evidence Repository.
BP5
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001114753.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENG
NM_001114753.3
MANE Select
c.-9G>A
5_prime_UTR_premature_start_codon_gain
Exon 1 of 15NP_001108225.1P17813-1
ENG
NM_001114753.3
MANE Select
c.-9G>A
5_prime_UTR
Exon 1 of 15NP_001108225.1P17813-1
ENG
NM_000118.4
c.-9G>A
5_prime_UTR_premature_start_codon_gain
Exon 1 of 14NP_000109.1Q5T9B9

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENG
ENST00000373203.9
TSL:1 MANE Select
c.-9G>A
5_prime_UTR_premature_start_codon_gain
Exon 1 of 15ENSP00000362299.4P17813-1
ENG
ENST00000344849.5
TSL:1
c.-9G>A
5_prime_UTR_premature_start_codon_gain
Exon 1 of 14ENSP00000341917.3P17813-2
ENG
ENST00000373203.9
TSL:1 MANE Select
c.-9G>A
5_prime_UTR
Exon 1 of 15ENSP00000362299.4P17813-1

Frequencies

GnomAD3 genomes
AF:
0.000414
AC:
63
AN:
152194
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000706
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000517
AC:
99
AN:
191406
AF XY:
0.000524
show subpopulations
Gnomad AFR exome
AF:
0.000263
Gnomad AMR exome
AF:
0.000172
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000294
Gnomad NFE exome
AF:
0.000847
Gnomad OTH exome
AF:
0.000398
GnomAD4 exome
AF:
0.000815
AC:
1167
AN:
1431220
Hom.:
1
Cov.:
31
AF XY:
0.000822
AC XY:
583
AN XY:
709318
show subpopulations
African (AFR)
AF:
0.000153
AC:
5
AN:
32730
American (AMR)
AF:
0.000174
AC:
7
AN:
40240
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25516
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37796
South Asian (SAS)
AF:
0.000722
AC:
59
AN:
81758
European-Finnish (FIN)
AF:
0.000196
AC:
10
AN:
50908
Middle Eastern (MID)
AF:
0.000176
AC:
1
AN:
5696
European-Non Finnish (NFE)
AF:
0.000965
AC:
1059
AN:
1097416
Other (OTH)
AF:
0.000439
AC:
26
AN:
59160
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
62
125
187
250
312
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000414
AC:
63
AN:
152194
Hom.:
0
Cov.:
33
AF XY:
0.000296
AC XY:
22
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41458
American (AMR)
AF:
0.000131
AC:
2
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000620
AC:
3
AN:
4836
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000706
AC:
48
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000758
Hom.:
0
Bravo
AF:
0.000408

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
2
2
not provided (5)
-
5
-
Telangiectasia, hereditary hemorrhagic, type 1 (5)
-
2
-
Hereditary hemorrhagic telangiectasia (2)
-
1
-
Cardiovascular phenotype (1)
-
-
1
ENG-related disorder (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
12
DANN
Benign
0.95
PhyloP100
0.065
PromoterAI
0.21
Neutral
Mutation Taster
=300/0
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs368423516; hg19: chr9-130616643; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.